Astellas Pharma
Search results
Jun 28, 2024 · Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.
The Takeda Pharmaceutical Company Limited (武田薬品工業株式会社, Takeda Yakuhin Kōgyō kabushiki gaisha) [takeꜜda jakɯçiŋ koꜜːɡʲoː] is a Japanese multinational pharmaceutical company.
Our vision is to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. This purpose-led and values-based approach is a core foundation of our global growth strategy and long-term value creation for our stakeholders. Learn more.
Our Products. The work we do transforms lives, helping patients with limited or no treatment options in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines.
With a rich history dating back to 1781 in Osaka, Japan, Takeda has grown into a global biopharmaceutical leader, operating in approximately 80 countries, including India. The company's mission in India focuses on ensuring sustainable access to healthcare, bolstered by strategic acquisitions and partnerships.
Mar 31, 2022 · Information on the corporate headquarters of Takeda Pharmaceutical Company Limited, Japan office locations, and key facts about the company.
Takeda | 1,304,840 followers on LinkedIn. Better Health, Brighter Future | We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring.
As a global biopharmaceutical leader, it's important to have a strong corporate philosophy. Since our founding in 1781, we have cultivated our corporate philosophy’s core components, which today we refer to as our purpose, values, vision and imperatives. These components are explained in detail here. Learn more.
May 13, 2024 · Japan’s Takeda Pharmaceuticals has reached a deal worth up to $2.2bn to develop an Alzheimer’s vaccine made by Swiss start-up AC Immune, as drug companies race to invest in potentially ...
Nov 9, 2023 · The U.S. Food and Drug Administration on Thursday approved Takeda Pharmaceutical's therapy to treat a rare genetic blood disorder in adult and pediatric patients.
